Literature DB >> 11512605

Rapid onset of pituitary apoplexy after goserelin implant for prostate cancer: need for heightened awareness.

H J Eaton, P J Phillips, A Hanieh, J Cooper, J Bolt, D J Torpy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11512605     DOI： 10.1046/j.1445-5994.2001.00065.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


× No keyword cloud information.
  8 in total

1.  Pituitary apoplexy: a rare complication of leuprolide therapy in prostate cancer treatment.

Authors:  Georges Tanios; Nicolas Andrews Mungo; Aaysha Kapila; Kailash Bajaj
Journal:  BMJ Case Rep       Date:  2017-07-14

2.  Pituitary apoplexy after leuprolide.

Authors:  Anu Davis; Shefali Goel; Michalis Picolos; Min Wang; Victor Lavis
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 3.  Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer.

Authors:  Yannis Guerra; Evelyn Lacuesta; Francisco Marquez; P B Raksin; Manuel Utset; Leon Fogelfeld
Journal:  Pituitary       Date:  2010       Impact factor: 4.107

4.  The presence of a pituitary tumor in patients with prostate cancer is not a contraindication for leuprolide therapy.

Authors:  Angela Babbo; George T Kalapurakal; Benjamin Liu; Sanija Bajramovic; James P Chandler; John Garnett; John A Kalapurakal
Journal:  Int Urol Nephrol       Date:  2014-04-06       Impact factor: 2.370

Review 5.  GnRH agonist-associated pituitary apoplexy: a case series and review of the literature.

Authors:  Francisco J Guarda; Xiaoling Yu; Philip J Saylor; Lisa B Nachtigall; Naila Shiraliyeva; Melanie S Haines; Michael Bradbury
Journal:  Pituitary       Date:  2021-04-09       Impact factor: 4.107

6.  Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment.

Authors:  Mariana Barbosa; Sílvia Paredes; Maria João Machado; Rui Almeida; Olinda Marques
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-06-04

7.  Pituitary apoplexy induced by Gonadotropin-releasing hormone agonists for treating prostate cancer-report of first Asian case.

Authors:  Tsung-Yi Huang; Jih-Pin Lin; Ann-Shung Lieu; Yi-Ting Chen; Hung-Sheng Chen; Mei-Yu Jang; Jung-Tsung Shen; Wen-Jeng Wu; Shu-Pin Huang; Yung-Shun Juan
Journal:  World J Surg Oncol       Date:  2013-10-02       Impact factor: 2.754

8.  Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.

Authors:  Rishi Raj; Ghada Elshimy; Aasems Jacob; P V Akhila Arya; Dileep C Unnikrishnan; Riccardo Correa; Zin W Myint
Journal:  J Cancer Res Clin Oncol       Date:  2021-06-22       Impact factor: 4.553
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.